The Advanced Research Projects Agency for Health (ARPA-H) is taking aim at the shortage of medical services with a program designed to foster development of micro-robots, or microbots, which will autonomously conduct part or all of a variety of surgical procedures. Read More

Mursla Bio Ltd. recently entered a partnership with an unnamed large pharmaceutical company to use its AI Precision Medicine platform to help with drug development and ultimately develop companion diagnostics. The collaboration uses Mursla’s platform ability to isolate and analyze extracellular vesicles from a simple blood sample, to provide biologically labelled, multiomics data to improve patient stratification, monitor treatment and develop companion diagnostics. Read More

Kakao Healthcare Corp. plans to secure ₩100 billion (US$68 million) through two investment deals with Cha Biomedical Group and outside investors by early next year. The transactions, expected to close by the first quarter of 2026, will make Cha the controlling shareholder of Kakao Healthcare with a 43.08% stake. Kakao Corp., the parent company, will hold 29.99%, and external investors will own 26.93%. Read More

The U.S. Centers for Medicare & Medicaid Services ended the Treatment Choices model under the end stage renal disease payment payment system for several reasons, including its failure to deliver meaningful savings. Read More

NIH researchers report that in severe influenza, survival improves at late stages only when antivirals are combined with therapies that repair lung damage or limit harmful T-cell responses, explaining why anti-inflammatory treatments alone are often ineffective. Read More

Managing Editor Anette Breindl talks about covering research breakthroughs that later became industry defining. Read More

New hires and promotions in the med-tech industry, including: Dionysus Health, Labstat, Edgeone. Read More

Med-tech firms raising money in public or private financings, including: Cordance, Thermo Fisher. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allurion, Caredx, Hinge Health. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Althea, Avicenna, BD, Enigma, Ferrum, Fluoguide, Invo, Lexagen, Nanox, Oasis Diagnostics, Ochre, Oludent Health, Ovation.io, Owlet, Precisionlife, Premier, Ziess. Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biocomposites, Bracco Diagnostics, Collagen Matrix, Ischemaview, Rapidai, Regenity. Read More